[ Price : $8.95]
Federal Register Notice: FDA plans a meeting of the Vaccines and Related Biological Products Advisory Committee 11/16 to discuss a...[ Price : $8.95]
Federal Register Notice: CDER and CDRH plan a conference 9/27-28 entitled: FDA Small Business and Industry Assistance Regulatory E...[ Price : $8.95]
Federal Register Notice: FDA plans a meeting of the Antimicrobial Drugs Advisory Committee 11/4 to discuss two Cempra Pharmaceutic...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Amniotic Therapies, Browns Compounding Center, Central Admixture Pharmacy Servic...[ Price : $8.95]
FDA approves a Sandoz BLA for Erelzi, (etanercept-szzs) a biosimilar copy of Amgens Enbrel (etanercept).[ Price : $8.95]
FDA accepts for review a CSL Behring BLA for its low-volume subcutaneous CSL830 (C1-esterase inhibitor (C1-INH) human) replacement...[ Price : $8.95]
FDA posts a final rule that requires drug/biologic makers to electronically submit, unless waived in certain circumstances, their ...[ Price : $8.95]
Federal Register Notice: FDA releases a revised draft guidance: Bioequivalence Recommendations for Risperidone.